Sfoglia per Rivista HAEMATOLOGICA
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement
2015-01-01 Girmenia, Corrado; Viscoli, Claudio; Piciocchi, Alfonso; Cudillo, Laura; Botti, Stefano; Errico, Antonio; Sarmati, Loredana; Ciceri, Fabio; Locatelli, Franco; Giannella, Maddalena; Bassetti, Matteo; Tascini, Carlo; Lombardini, Letizia; Majolino, Ignazio; Farina, Claudio; Luzzaro, Francesco; Rossolini, Gian Maria; Rambaldi, Alessandro
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
1999-01-01 Stocchi, R; Ward, Kn; Fanin, Renato; Baccarani, M; Apperley, Jf
“Mobilization of peripheral blood progenitor cells with G-CSF alone in lymphoma patients: steady state circulating progenitor cells count predicts the autograft yield”.
2000-01-01 Grimaz, S.; Damiani, Daniela; Michieli, M.; Baccarani, M.
MONITORING OF MINIMAL RESIDUAL DISEASE BY QUANTITATIVE WT1 GENE EXPRESSION AFTER REDUCED INTENSITY CONDITIONING ALLOGENEIC SCT IN ACUTE MYELOID LEUKEMIA
2009-01-01 Candoni, A.; Toffoletti, E.; Cavallin, M.; Michelutti, A.; Damiani, Daniela; Fanin, R.
MULTICENTER PROSPECTIVE CLINICAL TRIAL WITH LOW DOSE GEMTUZUMAB-OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN (GO-FLAI) AS INDUCTION THERAPY OF CD33-POSITIVE ACUTE MYELOID LEUKEMIA (AML) PATIENTS YOUNGER THAN 65 YEARS
2009-01-01 2. 2. 8. Candoni, A.; Martinelli, G.; Gherlinzoni, F.; Papayanidis, C.; Toffoletti, E.; Simeone, E.; Ottaviani, E.; Gottardi, M.; Iacobucci, I.; Paolini, S.; Michelutti, A.; Lama, B.; Calistri, E.; Visani, G.; Isidori, A.; Piccaluga, P. P.; Damiani, Daniela; Russo, D; Baccarani, M.; Fanin, R.
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia
2017-01-01 Bulian, Pietro; Bomben, Riccardo; Dal Bo, Michele; Zucchetto, Antonella; Rossi, Francesca Maria; Degan, Massimo; Pozzo, Federico; Bittolo, Tamara; Bravin, Vanessa; D’Agaro, Tiziana; Cerri, Michaela; Chiarenza, Annalisa; Chaffee, Kari G.; Condoluci, Adalgisa; D’Arena, Giovanni; Spina, Michele; Zaja, Francesco; Pozzato, Gabriele; Di Raimondo, Francesco; Rossi, Davide; Del Poeta, Giovanni; Gaidano, Gianluca; Shanafelt, Tait D.; Gattei, Valter
National systematic approach to the management of asplenia: the set up of the italian network on asplenia
2014-01-01 Casale, M.; Colombatti, R.; Sainati, L.; Casini, T.; Notarangelo, L.; Masera, N.; Russo, G.; Farruggia, P.; Vasta, I.; Capolsini, I.; Giordano, P.; Pusiol, A.; Capozzi, G.; Filosa, A.; Perrotta, S.
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients.
2016-01-01 Castagnetti, Fausto; Breccia, Massimo; Gugliotta, Gabriele; Martino, Bruno; D’Adda, Mariella; Stagno, Fabio; Carella, Angelo Michele; Avanzini, Paolo; Tiribelli, Mario; Trabacchi, Elena; Visani, Giuseppe; Gobbi, Marco; Salvucci, Marzia; Levato, Luciano; Binotto, Gianni; Capalbo, Silvana Franca; Bochicchio, Maria Teresa; Soverini, Simona; Cavo, Michele; Martinelli, Giovanni; Alimena, Giuliana; Pane, Fabrizio; Saglio, Giuseppe; Rosti, Gianantonio; Baccarani, Michele
No evidence for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy”
2008-01-01 Toffoletti, Eleonora; Zaja, Francesco; Chiarvesio, A; Michelutti, A; Battista, M; Fanin, Renato
Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous transplantation
2000-01-01 Patriarca, Francesca; Gaidano, G; Capello, D; Zaja, Francesco; Fanin, Renato
ORAL GENTAMICIN THERAPY FOR CARBAPENEM-RESISTENT KLEBSIELLA PNEUMONIAE INFECTIONS IN HEMATOLOGIC PATIENTS: A SINGLE CENTER EXPERIENCE
2016-01-01 Simonetti, F; Fortunato, S; Rousseau, M; Tascini, C; Menichetti, F; Stefanelli, A; Baccelli, E; Vettori, C; Petrini, M
Oucome of 131 consecutive patients with an high risk hematologic disease searching for an urelated donor.
2003-01-01 Sperotto, A.; Damiani, Daniela; Cerno, M.; Patirrca, F.; Silvestri, F.; Tiribelli, Mario; Geromin, A.; Zaja, Francesco; Skert, C.; Stocchi, R.; Candoni, A.; Fanin, R.
Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors.
2013-01-01 Russo Rossi, Av; Breccia, M; Abruzzese, E; Castagnetti, F; Luciano, L; Gozzini, A; Annunziata, M; Martino, B; Stagno, F; Cavazzini, F; Tiribelli, Mario; Visani, G; Pregno, P; Musto, P; Fava, C; Sgherza, N; Albano, F; Rosti, G; Alimena, G; Specchia, G.
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs
2020-01-01 Montefusco, V.; Gay, F.; Spada, S.; De Paoli, L.; Di Raimondo, F.; Ribolla, R.; Musolino, C.; Patriarca, F.; Musto, P.; Galieni, P.; Ballanti, S.; Nozzoli, C.; Cascavilla, N.; Ben-Yehuda, D.; Nagler, A.; Hajek, R.; Offidani, M.; Liberati, A. M.; Sonneveld, P.; Cavo, M.; Corradini, P.; Boccadoro, M.
OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANT FOR REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA
2009-01-01 Geromin, A.; Sperotto, A.; Patriarca, Francesca; Cerno, M.; Candoni, A.; Toffoletti, E.; Battista, M.; Medeot, M.; Damiani, Daniela; Fanin, R.
Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin.
1996-01-01 Michieli, M; Damiani, Daniela; Michelutti, A; Melli, C; Ermacora, A; Geromin, A; Fanin, Renato; Russo, D; Baccarani, M.
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia.
1994-01-01 Michelutti, A; Michieli, M; Damiani, Daniela; Melli, C; Geromin, A; Russo, D; Fanin, Renato; Baccarani, M.
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias
1998-01-01 Damiani, Daniela; Michieli, M.; Candoni, A.; Raspadori, D.; Geromin, A.; Stocchi, R.; Grimaz, S.; Masolini, P.; Michelutti, A.; Scheper, R. J.; Baccarani, M.
p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivatives
1994-01-01 Michieli, M.; Damiani, Daniela; Michelutti, A. Melli C.; Russo, D.; Fanin, Renato; Baccarani, M.
Peripheral blood stem cell mobilization in multiple myeloma: advantage of 7 vs. 4 g/m2 cyclophosfamide on stem cell quality and plasma cell mobilization.
2002-01-01 Damiani, Daniela; Masolini, P.; Stoccchi, R.; Michelutti, A.; Michieli, M.; Geromin, A.; Sperotto, A.; Skert, C.; Baccarani, M.; Fanin, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement | 1-gen-2015 | Girmenia, Corrado; Viscoli, Claudio; Piciocchi, Alfonso; Cudillo, Laura; Botti, Stefano; Errico, Antonio; Sarmati, Loredana; Ciceri, Fabio; Locatelli, Franco; Giannella, Maddalena; Bassetti, Matteo; Tascini, Carlo; Lombardini, Letizia; Majolino, Ignazio; Farina, Claudio; Luzzaro, Francesco; Rossolini, Gian Maria; Rambaldi, Alessandro | |
| Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. | 1-gen-1999 | Stocchi, R; Ward, Kn; Fanin, Renato; Baccarani, M; Apperley, Jf | |
| “Mobilization of peripheral blood progenitor cells with G-CSF alone in lymphoma patients: steady state circulating progenitor cells count predicts the autograft yield”. | 1-gen-2000 | Grimaz, S.; Damiani, Daniela; Michieli, M.; Baccarani, M. | |
| MONITORING OF MINIMAL RESIDUAL DISEASE BY QUANTITATIVE WT1 GENE EXPRESSION AFTER REDUCED INTENSITY CONDITIONING ALLOGENEIC SCT IN ACUTE MYELOID LEUKEMIA | 1-gen-2009 | Candoni, A.; Toffoletti, E.; Cavallin, M.; Michelutti, A.; Damiani, Daniela; Fanin, R. | |
| MULTICENTER PROSPECTIVE CLINICAL TRIAL WITH LOW DOSE GEMTUZUMAB-OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN (GO-FLAI) AS INDUCTION THERAPY OF CD33-POSITIVE ACUTE MYELOID LEUKEMIA (AML) PATIENTS YOUNGER THAN 65 YEARS | 1-gen-2009 | 2. 2. 8. Candoni, A.; Martinelli, G.; Gherlinzoni, F.; Papayanidis, C.; Toffoletti, E.; Simeone, E.; Ottaviani, E.; Gottardi, M.; Iacobucci, I.; Paolini, S.; Michelutti, A.; Lama, B.; Calistri, E.; Visani, G.; Isidori, A.; Piccaluga, P. P.; Damiani, Daniela; Russo, D; Baccarani, M.; Fanin, R. | |
| Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia | 1-gen-2017 | Bulian, Pietro; Bomben, Riccardo; Dal Bo, Michele; Zucchetto, Antonella; Rossi, Francesca Maria; Degan, Massimo; Pozzo, Federico; Bittolo, Tamara; Bravin, Vanessa; D’Agaro, Tiziana; Cerri, Michaela; Chiarenza, Annalisa; Chaffee, Kari G.; Condoluci, Adalgisa; D’Arena, Giovanni; Spina, Michele; Zaja, Francesco; Pozzato, Gabriele; Di Raimondo, Francesco; Rossi, Davide; Del Poeta, Giovanni; Gaidano, Gianluca; Shanafelt, Tait D.; Gattei, Valter | |
| National systematic approach to the management of asplenia: the set up of the italian network on asplenia | 1-gen-2014 | Casale, M.; Colombatti, R.; Sainati, L.; Casini, T.; Notarangelo, L.; Masera, N.; Russo, G.; Farruggia, P.; Vasta, I.; Capolsini, I.; Giordano, P.; Pusiol, A.; Capozzi, G.; Filosa, A.; Perrotta, S. | |
| Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients. | 1-gen-2016 | Castagnetti, Fausto; Breccia, Massimo; Gugliotta, Gabriele; Martino, Bruno; D’Adda, Mariella; Stagno, Fabio; Carella, Angelo Michele; Avanzini, Paolo; Tiribelli, Mario; Trabacchi, Elena; Visani, Giuseppe; Gobbi, Marco; Salvucci, Marzia; Levato, Luciano; Binotto, Gianni; Capalbo, Silvana Franca; Bochicchio, Maria Teresa; Soverini, Simona; Cavo, Michele; Martinelli, Giovanni; Alimena, Giuliana; Pane, Fabrizio; Saglio, Giuseppe; Rosti, Gianantonio; Baccarani, Michele | |
| No evidence for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy” | 1-gen-2008 | Toffoletti, Eleonora; Zaja, Francesco; Chiarvesio, A; Michelutti, A; Battista, M; Fanin, Renato | |
| Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous transplantation | 1-gen-2000 | Patriarca, Francesca; Gaidano, G; Capello, D; Zaja, Francesco; Fanin, Renato | |
| ORAL GENTAMICIN THERAPY FOR CARBAPENEM-RESISTENT KLEBSIELLA PNEUMONIAE INFECTIONS IN HEMATOLOGIC PATIENTS: A SINGLE CENTER EXPERIENCE | 1-gen-2016 | Simonetti, F; Fortunato, S; Rousseau, M; Tascini, C; Menichetti, F; Stefanelli, A; Baccelli, E; Vettori, C; Petrini, M | |
| Oucome of 131 consecutive patients with an high risk hematologic disease searching for an urelated donor. | 1-gen-2003 | Sperotto, A.; Damiani, Daniela; Cerno, M.; Patirrca, F.; Silvestri, F.; Tiribelli, Mario; Geromin, A.; Zaja, Francesco; Skert, C.; Stocchi, R.; Candoni, A.; Fanin, R. | |
| Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors. | 1-gen-2013 | Russo Rossi, Av; Breccia, M; Abruzzese, E; Castagnetti, F; Luciano, L; Gozzini, A; Annunziata, M; Martino, B; Stagno, F; Cavazzini, F; Tiribelli, Mario; Visani, G; Pregno, P; Musto, P; Fava, C; Sgherza, N; Albano, F; Rosti, G; Alimena, G; Specchia, G. | |
| Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs | 1-gen-2020 | Montefusco, V.; Gay, F.; Spada, S.; De Paoli, L.; Di Raimondo, F.; Ribolla, R.; Musolino, C.; Patriarca, F.; Musto, P.; Galieni, P.; Ballanti, S.; Nozzoli, C.; Cascavilla, N.; Ben-Yehuda, D.; Nagler, A.; Hajek, R.; Offidani, M.; Liberati, A. M.; Sonneveld, P.; Cavo, M.; Corradini, P.; Boccadoro, M. | |
| OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANT FOR REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA | 1-gen-2009 | Geromin, A.; Sperotto, A.; Patriarca, Francesca; Cerno, M.; Candoni, A.; Toffoletti, E.; Battista, M.; Medeot, M.; Damiani, Daniela; Fanin, R. | |
| Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin. | 1-gen-1996 | Michieli, M; Damiani, Daniela; Michelutti, A; Melli, C; Ermacora, A; Geromin, A; Fanin, Renato; Russo, D; Baccarani, M. | |
| Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia. | 1-gen-1994 | Michelutti, A; Michieli, M; Damiani, Daniela; Melli, C; Geromin, A; Russo, D; Fanin, Renato; Baccarani, M. | |
| P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias | 1-gen-1998 | Damiani, Daniela; Michieli, M.; Candoni, A.; Raspadori, D.; Geromin, A.; Stocchi, R.; Grimaz, S.; Masolini, P.; Michelutti, A.; Scheper, R. J.; Baccarani, M. | |
| p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivatives | 1-gen-1994 | Michieli, M.; Damiani, Daniela; Michelutti, A. Melli C.; Russo, D.; Fanin, Renato; Baccarani, M. | |
| Peripheral blood stem cell mobilization in multiple myeloma: advantage of 7 vs. 4 g/m2 cyclophosfamide on stem cell quality and plasma cell mobilization. | 1-gen-2002 | Damiani, Daniela; Masolini, P.; Stoccchi, R.; Michelutti, A.; Michieli, M.; Geromin, A.; Sperotto, A.; Skert, C.; Baccarani, M.; Fanin, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile